Embracing cancer complexity: Hallmarks of systemic disease
The last 50 years have witnessed extraordinary developments in understanding
mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical …
mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical …
Cardiovascular disease related circulating biomarkers and cancer incidence and mortality: is there an association?
Aims Recent studies suggest an association between cardiovascular disease (CVD) and
cancer incidence/mortality, but the pathophysiological mechanisms underlying these …
cancer incidence/mortality, but the pathophysiological mechanisms underlying these …
Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy
NS Klee, CG McCarthy… - Therapeutic …, 2017 - journals.sagepub.com
Cardio-oncology is a new and rapidly expanding field that merges cancer and
cardiovascular disease. Cardiovascular disease is an omnipresent side effect of cancer …
cardiovascular disease. Cardiovascular disease is an omnipresent side effect of cancer …
Association of cardiometabolic disease with cancer in the community
EE Liu, N Suthahar, SM Paniagua, D Wang, ES Lau… - Cardio Oncology, 2022 - jacc.org
Background Obesity and cardiometabolic dysfunction have been associated with cancer risk
and severity. Underlying mechanisms remain unclear. Objectives The aim of this study was …
and severity. Underlying mechanisms remain unclear. Objectives The aim of this study was …
Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity
EA Bayliss, LM Reifler, C Zeng… - Journal of …, 2014 - journals.sagepub.com
Background Cancer patients with cardiovascular and other comorbidities are at concurrent
risk of multiple adverse outcomes. However, most treatment decisions are guided by …
risk of multiple adverse outcomes. However, most treatment decisions are guided by …
[HTML][HTML] Incidence of cancers in patients with atherosclerotic cardiovascular diseases
M Suzuki, H Tomoike, T Sumiyoshi, Y Nagatomo… - IJC heart & …, 2017 - Elsevier
Background To address a clinical impact of atherosclerotic cardiovascular diseases (CVD)
on cancer developments, we investigated an issue whether any difference in an incidence of …
on cancer developments, we investigated an issue whether any difference in an incidence of …
Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers
J Sun, J Luo, F Jiang, J Zhao, S Zhou… - JNCI: Journal of the …, 2024 - academic.oup.com
Background The proteome is an important reservoir of potential therapeutic targets for
cancer. This study aimed to examine the causal associations between plasma proteins and …
cancer. This study aimed to examine the causal associations between plasma proteins and …
Bidirectional association between cardiovascular disease and lung cancer in a prospective cohort study
S Zhang, L Liu, S Shi, H He, Q Shen, H Wang… - Journal of Thoracic …, 2024 - Elsevier
Introduction The study aimed to prospectively investigate the bidirectional association
between cardiovascular disease (CVD) and lung cancer, and whether this association …
between cardiovascular disease (CVD) and lung cancer, and whether this association …
Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study
B Xia, J Peng, DT Enrico, K Lu, EC Cheung, Z Kuo… - BMC cancer, 2021 - Springer
Abstract Background & Aims Little is known on the gender-specific effect and potential role
of non-linear associations between metabolic syndrome (MetS) components and liver …
of non-linear associations between metabolic syndrome (MetS) components and liver …
Population-attributable fractions of personal comorbidities for liver, gallbladder, and bile duct cancers
K Hemminki, K Sundquist, J Sundquist, A Försti… - Cancers, 2023 - mdpi.com
Simple Summary Liver cancer is often used as a general term for cancers of the liver
(hepatocellular carcinoma, HCC), the gallbladder, and the bile ducts. The well-known risk …
(hepatocellular carcinoma, HCC), the gallbladder, and the bile ducts. The well-known risk …